OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
72
Results
Show all
Save search
Copy query
Show results for
Unknown
(72)
Release Date
2020
(11)
2023
(10)
2021
(9)
2022
(7)
2016
(7)
2025
(6)
2024
(5)
2019
(5)
2017
(3)
2015
(3)
2011
(2)
2026
(1)
2018
(1)
2013
(1)
2004
(1)
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
Chemico-Biological Characterization of Torpedino Di Fondi® Tomato Fruits: A Comparison with San Marzano Cultivar at Two Ripeness Stages.
Not available
S-EPMC7590105
|
biostudies-literature
Cite
Characterization of the Phytochemical Composition and Bioactivities of
Anacyclus maroccanus
Ball. and
Anacyclus radiatus
Loisel Aerial Parts: Preliminary Evidence for the Possible Development of Moroccan Plants.
Not available
S-EPMC8839974
|
biostudies-literature
Cite
Cavity-Based Discovery of New Fatty Acid Photodecarboxylases.
Not available
S-EPMC11664916
|
biostudies-literature
Cite
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.
Not available
S-EPMC4422815
|
biostudies-literature
Cite
One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: a pilot study from the NU-AGE project.
Not available
S-EPMC7205853
|
biostudies-literature
Cite
Immunotherapy of brain metastases: breaking a "dogma".
Not available
S-EPMC6798349
|
biostudies-literature
Cite
From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma.
Not available
S-EPMC10083011
|
biostudies-literature
Cite
KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in
BRAF
-mutant melanoma.
Not available
S-EPMC7768966
|
biostudies-literature
Cite
A novel microRNA signature for the detection of melanoma by liquid biopsy.
Not available
S-EPMC9571479
|
biostudies-literature
Cite
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
Not available
S-EPMC10323889
|
biostudies-literature
Cite
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets